The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
The fate of chemoresistance in triple negative breast cancer (TNBC)
Open accessAbstract
BACKGROUND: Treatment options for women presenting with triple negative breast cancer (TNBC) are limited due to the lack of a therapeutic target and as a result, are managed with standard chemotherapy such as paclitaxel (Taxol®). Following chemotherapy, the ideal tumour response is apoptotic cell death. Post-chemotherapy, cells can maintain viability by undergoing viable cellular responses such as cellular senescence, generating secretomes which can directly enhance the malignant phenotype. SCOPE OF REVIEW: How tumour cells retain viability in response to chemotherapeutic engagement is discussed. In addition we discuss the implications of this retained tumour cell viability in the context of the development of recurrent and metastatic TNBC disease. Current adjuvant and neo-adjuvant treatments available and the novel potential therapies that are being researched are also reviewed. MAJOR CONCLUSIONS: Cellular senescence and cytoprotective autophagy are potential mechanisms of chemoresistance in TNBC. These two non-apoptotic outcomes in response to chemotherapy are inextricably linked and are neglected outcomes of investigation in the chemotherapeutic arena. Cellular fate assessments may therefore have the potential to predict TNBC patient outcome. GENERAL SIGNIFICANCE: Focusing on the fact that cancer cells can bypass the desired cellular apoptotic response to chemotherapy through cellular senescence and cytoprotective autophagy will highlight the importance of targeting non-apoptotic survival pathways to enhance chemotherapeutic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
RetractedSamanta, D., Gilkes, D. M., Chaturvedi, P., Xiang, L., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421438111 · Cited by 460
RetractedPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Triple-negative breast cancer: clinical features and patterns of recurrence
Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6529 · Cited by 4,213
Wolff, A. C., Hammond, M. E. H., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H., Allred, D. C., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.9984 · Cited by 4,030
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Liedtke, C., Mazouni, C., Hess, K. R., André, F., Tordai, A., Mejia, J. A., Symmans, W. F., Gonzalez-Angulo, A. M., Hennessy, B., Green, M., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4147 · Cited by 2,892
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
Audeh, M. W., Carmichael, J., Penson, R. T., Friedlander, M., Powell, B., Bell-McGuinn, K. M., Scott, C., Weitzel, J. N., Oaknin, A., Loman, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60893-8 · Cited by 2,279
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Carey, L. A., Dees, E. C., Sawyer, L., Gatti, L., Moore, D. T., Collichio, F., Ollila, D. W., Sartor, C. I., Graham, M. L., & Perou, C. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1109 · Cited by 2,087
Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gélinas, C., Fan, Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.001 · Cited by 2,011
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798
Wolff, A. C., Hammond, M. E. H., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H., Allred, D. C., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., et al. (2014) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2013-0953-sa · Cited by 1,762
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
Autophagy in cell death: an innocent convict?
Levine, B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26390 · Cited by 1,676
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,672
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N., Tutt, A., & Ashworth, A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1457 · Cited by 1,657
Tutt, A., Robson, M., Garber, J. E., Domchek, S. M., Audeh, M. W., Weitzel, J. N., Friedlander, M., Arun, B., Loman, N., Schmutzler, R. K., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60892-6 · Cited by 1,655
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouysségur, J., & Mazure, N. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-09 · Cited by 1,501
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Adams, S., Gray, R. J., Demaria, S., Goldstein, L., Perez, E. A., Shulman, L. N., Martino, S., Wang, M., Jones, V. E., Saphner, T. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0491 · Cited by 1,299
Cancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
Cheang, M. C. U., Voduc, D., Bajdik, C., Leung, S., McKinney, S., Chia, S. K., Perou, C. M., & Nielsen, T. O. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1658 · Cited by 1,195
Basal-Like Breast Cancer: A Critical Review
Rakha, E. A., Reis-Filho, J. S., & Ellis, I. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.1748 · Cited by 1,164
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Lactate: A Metabolic Key Player in Cancer
Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,090
Haffty, B. G., Yang, Q., Reiss, M., Kearney, T., Higgins, S. A., Weidhaas, J., Harris, L., Hait, W., & Toppmeyer, D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5664 · Cited by 1,084
Sikov, W. M., Berry, D. A., Perou, C. M., Singh, B., Cirrincione, C. T., Tolaney, S. M., Kuzma, C. S., Pluard, T. J., Somlo, G., Port, E. R., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.0572 · Cited by 1,013
Fong, P. C., Yap, T. A., Boss, D. S., Carden, C. P., Mergui-Roelvink, M., Gourley, C., De Greve, J., Lubinski, J., Shanley, S., Messiou, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9589 · Cited by 1,010
Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
Foulkes, W. D. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg050 · Cited by 970
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., & Sawyers, C. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171076798 · Cited by 969
Hennessy, B. T., Gonzalez-Angulo, A.-M., Stemke-Hale, K., Gilcrease, M. Z., Krishnamurthy, S., Lee, J.-S., Fridlyand, J., Sahin, A., Agarwal, R., Joy, C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3441 · Cited by 874
O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., et al. (1997) · PubMed · Cited by 867
The Fanconi anaemia/BRCA pathway
D'Andrea, A. D., & Grompe, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc970 · Cited by 822
Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer
O'Shaughnessy, J., Osborne, C., Pippen, J. E., Yoffe, M., Patt, D., Rocha, C., Koo, I. C., Sherman, B. M., & Bradley, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011418 · Cited by 817
Autophagy as a target for anticancer therapy
Janku, F., McConkey, D. J., Hong, D. S., & Kurzrock, R. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.71 · Cited by 803
Press, M. F., Bernstein, L., Thomas, P. A., Meisner, L. F., Zhou, J. Y., Ma, Y., Hung, G., Robinson, R. A., Harris, C., El-Naggar, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2894 · Cited by 802
Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
van der Groep, P., Bouter, A., van der Zanden, R., Menko, F. H., Buerger, H., Verheijen, R. H. M., van der Wall, E., & van Diest, P. J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh114 · Cited by 798
Triple-Negative Breast Cancer: An Unmet Medical Need
Hudis, C. A., & Gianni, L. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-s1-01 · Cited by 780
Scharenberg, C. W., Harkey, M. A., & Torok-Storb, B. (2002) · Blood · doi:10.1182/blood.v99.2.507 · Cited by 770
Aas, T., Børresen, A.-L., Geisler, S., Smith-Sørensen, B., Johnsen, H., Varhaug, J. E., Akslen, L. A., & Lønning, P. E. (1996) · Nature Medicine · doi:10.1038/nm0796-811 · Cited by 736
Mechanisms of chemoresistance in cancer stem cells
Abdullah, L. N., & Chow, E. K. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-3 · Cited by 721
Estrogen Receptors in Human Breast Cancer
McGuire, W. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107175 · Cited by 668
Targeting the mTOR Signaling Network for Cancer Therapy
Meric-Bernstam, F., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.0766 · Cited by 639
Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
Anders, C. K., & Carey, L. A. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.s.008 · Cited by 625
Lakhani, S. R., Reis-Filho, J. S., Fulford, L., Penault-Llorca, F., van der Vijver, M., Parry, S., Bishop, T., Benitez, J., Rivas, C., Bignon, Y.-J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2424 · Cited by 611
Doane, A. S., Danso, M., Lal, P., Donaton, M., Zhang, L., Hudis, C., & Gerald, W. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209415 · Cited by 603
Morris, G. J., Naidu, S., Topham, A. K., Guiles, F., Xu, Y., McCue, P., Schwartz, G. F., Park, P. K., Rosenberg, A. L., Brill, K., et al. (2007) · Cancer · doi:10.1002/cncr.22836 · Cited by 602
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Bhola, N. E., Balko, J. M., Dugger, T. C., Kuba, M. G., Sánchez, V., Sanders, M., Stanford, J., Cook, R. S., & Arteaga, C. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65416 · Cited by 590
Dumontet, C., & Sikic, B. I. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1061 · Cited by 574
Gonzalez-Angulo, A. M., Timms, K. M., Liu, S., Chen, H., Litton, J. K., Potter, J., Lanchbury, J. S., Stemke-Hale, K., Hennessy, B. T., Arun, B. K., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2560 · Cited by 573
Dice, J. F. (2007) · Autophagy · doi:10.4161/auto.4144 · Cited by 569
Apoptosis and autophagy: regulatory connections between two supposedly different processes
Thorburn, A. (2008) · Apoptosis · doi:10.1007/s10495-007-0154-9 · Cited by 555
(1996) · PubMed · Cited by 554
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
von Minckwitz, G., Eidtmann, H., Rezai, M., Fasching, P. A., Tesch, H., Eggemann, H., Schrader, I., Kittel, K., Hanusch, C., Kreienberg, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111065 · Cited by 530
HIF-Dependent Antitumorigenic Effect of Antioxidants In Vivo
Gao, P., Zhang, H., Dinavahi, R., Li, F., Xiang, Y., Raman, V., Bhujwalla, Z. M., Felsher, D. W., Cheng, L., Pevsner, J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.004 · Cited by 523
Carey, L. A., Rugo, H. S., Marcom, P. K., Mayer, E. L., Esteva, F. J., Ma, C. X., Liu, M. C., Storniolo, A. M., Rimawi, M. F., Forero-Torres, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.5579 · Cited by 499
Burstein, H. J., Elias, A. D., Rugo, H. S., Cobleigh, M. A., Wolff, A. C., Eisenberg, P. D., Lehman, M., Adams, B. J., Bello, C. L., DePrimo, S. E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.5375 · Cited by 489
Semenza, G. L. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.08.006 · Cited by 483
Balko, J. M., Giltnane, J. M., Wang, K., Schwarz, L. J., Young, C. D., Cook, R. S., Owens, P., Sanders, M. E., Kuba, M. G., Sánchez, V., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0286 · Cited by 482
Thomas, E. S., Gomez, H. L., Li, R. K., Chung, H.-C., Fein, L. E., Chan, V. F., Jassem, J., Pivot, X. B., Klimovsky, J. V., de Mendoza, F. H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.6557 · Cited by 481
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
Bear, H. D., Tang, G., Rastogi, P., Geyer, C. E., Robidoux, A., Atkins, J. N., Baez-Diaz, L., Brufsky, A. M., Mehta, R. S., Fehrenbacher, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1111097 · Cited by 461
Jacobs, T. W., Gown, A. M., Yaziji, H., Barnes, M. J., & Schnitt, S. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.1983 · Cited by 457
Triple-Negative Breast Cancer: Risk Factors to Potential Targets
Schneider, B. P., Winer, E. P., Foulkes, W. D., Garber, J., Perou, C. M., Richardson, A., Sledge, G. W., & Carey, L. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1208 · Cited by 437
Treatment-Related Mortality With Bevacizumab in Cancer Patients: A Meta-analysis
Ranpura, V., Hapani, S., & Wu, S. (2011) · JAMA · doi:10.1001/jama.2011.51 · Cited by 428
Thomas, E. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5019 · Cited by 428
Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V, Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.126 · Cited by 421
Finn, R. S., Dering, J., Ginther, C., Wilson, C. A., Glaspy, P., Tchekmedyian, N., & Slamon, D. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9463-x · Cited by 409
Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A. K., Birbe, R., Howell, A., Pavlides, S., Gandara, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15659 · Cited by 409
Azad, M. B., Chen, Y., Henson, E. S., Cizeau, J., McMillan-Ward, E., Israels, S. J., & Gibson, S. B. (2008) · Autophagy · doi:10.4161/auto.5278 · Cited by 355
De Flora, S., Izzotti, A., D'Agostini, F., & Balansky, R. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.7.999 · Cited by 351
Understanding and treating triple-negative breast cancer
Carey, L., & Anders, C. (2021) · PubMed · doi:10.17615/85ph-f542 · Cited by 351
Cosse, J.-P., & Michiels, C. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008785914798 · Cited by 348 · cited 1×
“This compromises the cells biological functions with a concomitant increase in compensatory glycolysis [156].”
BackgroundLinderholm, B. K., Hellborg, H., Johansson, U., Elmberger, G., Skoog, L., Lehtiö, J., & Lewensohn, R. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp062 · Cited by 347
Expression of androgen receptors in primary breast cancer
Park, S., Koo, J., Park, H. S., Kim, J.-H., Choi, S.-Y., Lee, J. H., Park, B.-W., & Lee, K. S. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp510 · Cited by 343
Yang, G., Rosen, D. G., Zhang, Z., Bast, R. C., Mills, G. B., Colacino, J. A., Mercado-Uribe, I., & Liu, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605752103 · Cited by 341
André, F., & Zielinski, C. C. (2012) · Annals of Oncology · doi:10.1093/annonc/mds195 · Cited by 329
Plathow, C., & Weber, W. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.045930 · Cited by 328
Lebeau, A., Deimling, D., Kaltz, C., Sendelhofert, A., Iff, A., Luthardt, B., Untch, M., & Löhrs, U. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.354 · Cited by 326
Triple negative breast cancer: unmet medical needs
Pal, S. K., Childs, B. H., & Pegram, M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1293-1 · Cited by 322
Characteristics of triple-negative breast cancer
de Ruijter, T. C., Veeck, J., de Hoon, J. P. J., van Engeland, M., & Tjan-Heijnen, V. C. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0957-x · Cited by 317
Crosstalk Between Autophagy and Apoptosis in Heart Disease
Nishida, K., Yamaguchi, O., & Otsu, K. (2008) · Circulation Research · doi:10.1161/circresaha.108.175448 · Cited by 316
Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers
Bertucci, F., Finetti, P., Cervera, N., Charafe-Jauffret, E., Mamessier, E., Adélaïde, J., Debono, S., Houvenaeghel, G., Maraninchi, D., Viens, P., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0031 · Cited by 310
Cancer and aging: a model for the cancer promoting effects of the aging stroma
Krtolica, A., & Campisi, J. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00053-5 · Cited by 295
Determinants of Rapamycin Sensitivity in Breast Cancer Cells
Noh, W.-C., Mondesire, W. H., Peng, J., Jian, W., Zhang, H., Dong, J., Mills, G. B., Hung, M.-C., & Meric-Bernstam, F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0043 · Cited by 285
Molecular mechanisms of drug resistance
Hayes, J. D., & Wolf, C. R. (1990) · Biochemical Journal · doi:10.1042/bj2720281 · Cited by 279
Sun, T., Aceto, N., Meerbrey, K. L., Kessler, J. D., Zhou, C., Migliaccio, I., Nguyen, D. X., Pavlova, N. N., Botero, M., Huang, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.02.003 · Cited by 276
Bergh, J., Bondarenko, I. M., Lichinitser, M. R., Liljegren, A., Greil, R., Voytko, N. L., Makhson, A. N., Cortes, J., Lortholary, A., Bischoff, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.7376 · Cited by 264
ATP binding cassette transporters and drug resistance in breast cancer.
Leonessa, F., & Clarke, R. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100043 · Cited by 259
Ellard, S. L., Clemons, M., Gelmon, K. A., Norris, B., Kennecke, H., Chia, S., Pritchard, K., Eisen, A., Vandenberg, T., Taylor, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3033 · Cited by 258
Oxidative Stress and Autophagy in Cardiac Disease, Neurological Disorders, Aging and Cancer
Essick, E. E., & Sam, F. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.3.12106 · Cited by 249
Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Pestell, R. G., Tanowitz, H. B., Sotgia, F., & Lisanti, M. P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.01.023 · Cited by 248
Basu, S., Chen, W., Tchou, J., Mavi, A., Cermik, T., Czerniecki, B., Schnall, M., & Alavi, A. (2008) · Cancer · doi:10.1002/cncr.23226 · Cited by 248
Autophagy regulation and its role in cancer
Lorin, S., Hamaï, A., Mehrpour, M., & Codogno, P. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.007 · Cited by 245
O'Shaughnessy, J., Schwartzberg, L. S., Danso, M. A., Rugo, H. S., Miller, K., Yardley, D. A., Carlson, R. W., Finn, R. S., Charpentier, E., Freese, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.1007 · Cited by 245
Witkiewicz, A. K., Whitaker-Menezes, D., Dasgupta, A., Philp, N. J., Lin, Z., Gandara, R., Sneddon, S., Martinez-Outschoorn, U. E., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19530 · Cited by 239
Chacón, R. D., & Costanzo, M. V. (2010) · Breast Cancer Research · doi:10.1186/bcr2574 · Cited by 239
Ueda, S., Tsuda, H., Asakawa, H., Shigekawa, T., Fukatsu, K., Kondo, N., Yamamoto, M., Hama, Y., Tamura, K., Ishida, J., et al. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn019 · Cited by 233
Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study
Finn, R. S., Bengala, C., Ibrahim, N., Roché, H., Sparano, J., Strauss, L. C., Fairchild, J., Sy, O., & Goldstein, L. J. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0288 · Cited by 220
Molecular mechanism and regulation of autophagy1
YANG, Y.-P., LIANG, Z.-Q., GU, Z.-L., & QIN, Z.-H. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00235.x · Cited by 214
Sládek, N. E., Kollander, R., Sreerama, L., & Kiang, D. T. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-001-0412-4 · Cited by 212
Emerging targeted therapies in triple-negative breast cancer
Crown, J., O'Shaughnessy, J., & Gullo, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds196 · Cited by 208
The role of p53 in hypoxia-induced apoptosis
Hammond, E. M., & Giaccia, A. J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.154 · Cited by 205
Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer
Gonzalez-Angulo, A. M., Stemke-Hale, K., Palla, S. L., Carey, M., Agarwal, R., Meric-Berstam, F., Traina, T. A., Hudis, C., Hortobagyi, G. N., Gerald, W. L., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1763 · Cited by 205
Tumor Suppression and Promotion by Autophagy
Ávalos, Y., Canales, J., Bravo-Sagua, R., Criollo, A., Lavandero, S., & Quest, A. F. G. (2014) · BioMed Research International · doi:10.1155/2014/603980 · Cited by 196
Tan, E. Y., Yan, M., Campo, L., Han, C., Takano, E., Turley, H., Candiloro, I., Pezzella, F., Gatter, K. C., Millar, E. K. A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604844 · Cited by 195
Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells
Xi, G., Hu, X., Wu, B., Jiang, H., Young, C. Y. F., Pang, Y., & Yuan, H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.03.026 · Cited by 193
Viale, G., Rotmensz, N., Maisonneuve, P., Bottiglieri, L., Montagna, E., Luini, A., Veronesi, P., Intra, M., Torrisi, R., Cardillo, A., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0206-z · Cited by 190
Bauer, J. A., Chakravarthy, A. B., Rosenbluth, J. M., Mi, D., Seeley, E. H., De Matos Granja-Ingram, N., Olivares, M. G., Kelley, M. C., Mayer, I. A., Meszoely, I. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1091 · Cited by 187
Autophagy in disease: a double-edged sword with therapeutic potential
Martinet, W., Agostinis, P., Vanhoecke, B., Dewaele, M., & de Meyer, G. R. Y. (2009) · Clinical Science · doi:10.1042/cs20080508 · Cited by 186
Dent, R. A., Lindeman, G. J., Clemons, M., Wildiers, H., Chan, A., McCarthy, N. J., Singer, C. F., Lowe, E. S., Watkins, C. L., & Carmichael, J. (2013) · Breast Cancer Research · doi:10.1186/bcr3484 · Cited by 184
Imaging of triple-negative breast cancer
Dogan, B. E., & Turnbull, L. W. (2012) · Annals of Oncology · doi:10.1093/annonc/mds191 · Cited by 182
Sotgia, F., Martinez-Outschoorn, U. E., Pavlides, S., Howell, A., Pestell, R. G., & Lisanti, M. P. (2011) · Breast Cancer Research · doi:10.1186/bcr2892 · Cited by 177
Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer
Tutt, A., Robson, M., Garber, J. E., Domchek, S., Audeh, M. W., Weitzel, J. N., Friedlander, M., & Carmichael, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.cra501 · Cited by 174
Alli, E., Sharma, V. B., Sunderesakumar, P., & Ford, J. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4016 · Cited by 171
Targeting triple-negative breast cancer: optimising therapeutic outcomes
Gelmon, K., Dent, R., Mackey, J. R., Laing, K., McLeod, D., & Verma, S. (2012) · Annals of Oncology · doi:10.1093/annonc/mds067 · Cited by 171
Transcriptional up-regulation of ULK1 by ATF4 contributes to cancer cell survival
Pike, L., Singleton, D. C., Buffa, F. M., Abramczyk, O., Phadwal, K., Li, J., Simon, A. K., Murray, J. T., & Harris, A. L. (2012) · Biochemical Journal · doi:10.1042/bj20120972 · Cited by 170
Steelman, L. S., Navolanic, P. M., Sokolosky, M. L., Taylor, J. R., Lehmann, B. D., Chappell, W. H., Abrams, S. L., Wong, E. W. T., Stadelman, K. M., Terrian, D. M., et al. (2008) · Oncogene · doi:10.1038/onc.2008.49 · Cited by 170
Autophagy as a mediator of chemotherapy-induced cell death in cancer
Notte, A., Leclere, L., & Michiels, C. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.015 · Cited by 166
Stagg, J., & Allard, B. (2013) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012475152 · Cited by 166
Poly(ADP-Ribose) Polymerase Inhibition: “Targeted” Therapy for Triple-Negative Breast Cancer
Anders, C. K., Winer, E. P., Ford, J. M., Dent, R. A., Silver, D. P., Sledge, G. W., & Carey, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0939 · Cited by 159
Determination of Four Sequential Stages during Microautophagy in Vitro
Kunz, J. B., Schwarz, H., & Mayer, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307905200 · Cited by 157
Isakoff, S. J., Overmoyer, B. A., Tung, N., Gelman, R. S., Giranda, V. L., Bernhard, K. M., Habin, K. R., Ellisen, L. W., Winer, E. P., & Goss, P. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.1019 · Cited by 152
Alba, E., Chacón, J. I., Lluch, A. M., Anton, A., Estevez, L., Cirauqui, B., Carrasco, E., Calvo, L., Seguí, M. Á., Ribelles, N., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2100-y · Cited by 147
Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β‐tubulins
Tommasi, S., Mangia, A., Lacalamita, R., Bellizzi, A., Fedele, V., Chiriatti, A., Thomssen, C., Kendzierski, N., Latorre, A. C., Lorusso, V., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22557 · Cited by 145
Autophagy, Stress, and Cancer Metabolism: What Doesn't Kill You Makes You Stronger
Mathew, R., & White, E. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.011015 · Cited by 145
P‐Glycoprotein‐Mediated Hoechst 33342 Transport Out of the Lipid Bilayer
Shapiro, A. B., Corder, A. B., & Ling, V. W. T. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00115.x · Cited by 144
Therapeutic targets in triple negative breast cancer
O'Toole, S. A., Beith, J. M., Millar, E. K. A., West, R. H., McLean, A. E. B., Cazet, A., Swarbrick, A., & Oakes, S. R. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2012-201361 · Cited by 143
Ramírez, L. V., Sánchez‐Rovira, P., Ramírez-Tortosa, M. C., Ramírez-Tortosa, C. L., Granados-Principal, S. M., Lorente, J. A., & Quiles, J. L. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.01.004 · Cited by 142
Beclin 1 deficiency is associated with increased hypoxia-induced angiogenesis
Lee, S., Kim, H.-P., Jin, Y., Choi, A. M. K., & Ryter, S. W. (2011) · Autophagy · doi:10.4161/auto.7.8.15598 · Cited by 137
Gucalp, A., & Traina, T. A. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181ce4ae1 · Cited by 131
Selvendiran, K., Bratasz, A., Kuppusamy, M. L., Tazi, M., Rivera, B. K., & Kuppusamy, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.24601 · Cited by 130
Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia
Flamant, L., Notte, A., Ninane, N., Raes, M., & Michiels, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-191 · Cited by 130
Zhao, H., Yang, M., Zhao, J., Wang, J., Zhang, Y., & Zhang, Q. (2013) · Medical Oncology · doi:10.1007/s12032-013-0475-1 · Cited by 125
Milane, L. S., Duan, Z., & Amiji, M. M. (2011) · Cancer Cell International · doi:10.1186/1475-2867-11-3 · Cited by 122
Cao, M. D., Sitter, B., Bathen, T. F., Bofin, A. M., Lønning, P. E., Lundgren, S., & Gribbestad, I. S. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1762 · Cited by 120
Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer
Tutt, A. N. J., Robson, M. E., Garber, J. E., Domchek, S. M., Audeh, M. W., Weitzel, J. N., Friedlander, M. L., & Carmichael, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.18_suppl.cra501 · Cited by 120
Resistance to topoisomerase poisons due to loss of DNA mismatch repair
Fedier, A., Schwarz, V. A., Walt, H., Carpini, R. D., Haller, U., & Fink, D. A. (2001) · International Journal of Cancer · doi:10.1002/ijc.1356 · Cited by 117
Novel Insights into the Interplay between Apoptosis and Autophagy
Rikiishi, H. (2012) · International Journal of Cell Biology · doi:10.1155/2012/317645 · Cited by 116
Choi, J., Kim, D. H., Jung, W. H., & Koo, J. S. (2013) · Breast Cancer Research · doi:10.1186/bcr3472 · Cited by 115
A Novel Function for the Tumor Suppressor p16INK4a
Plath, T., Detjen, K. M., Welzel, M., von Marschall, Z., Murphy, D. B., Schirner, M., Wiedenmann, B., & Rosewicz, S. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.6.1467 · Cited by 114
Generation of an epigenetic signature by chronic hypoxia in prostate cells
Watson, J. A., Watson, C. J., McCrohan, A., Woodfine, K., Tosetto, M., McDaid, J., Gallagher, E., Betts, D., Baugh, J. A., O'Sullivan, J. N., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp307 · Cited by 113
Self-citationChakrabarti, J., Turley, H., Campo, L., Han, C., Harris, A. L., Gatter, K. C., & Fox, S. B. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602059 · Cited by 112
Groheux, D., Hindié, E., Giacchetti, S., et al. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.094045 · Cited by 111
Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
Bedard, P. L., Leo, A. D., & Piccart, M. J. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.186 · Cited by 110
Gonzalez-Angulo, A. M., Akçakanat, A., Liu, S., Green, M. C., Murray, J. L., Chen, H., Palla, S. L., Koenig, K. B., Brewster, A. M., Valero, V., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu124 · Cited by 110
Hypoxia and Senescence: The Impact of Oxygenation on Tumor Suppression
Welford, S. M., & Giaccia, A. J. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0065 · Cited by 108
Singel, S. M., Cornelius, C., Zaganjor, E., Batten, K. G., Sarode, V. R., Buckley, D. L., Peng, Y. S., John, G. B., Li, H. C., Sadeghi, N., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.03.008 · Cited by 107
Shorter duration of oral N -Acetylcysteine therapy for acute acetaminophen overdose
Woo, O. F., Mueller, P. D., Olson, K. R., Anderson, I. B., & Kim, S. Y. (2000) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(00)70055-2 · Cited by 106
The Paradox of Triple Negative Breast Cancer: Novel Approaches to Treatment
Fornier, M. N., & Fumoleau, P. (2011) · The Breast Journal · doi:10.1111/j.1524-4741.2011.01175.x · Cited by 103
Oncogene-specific formation of chemoresistant murine hepatic cancer stem cells
Chow, E. K., Fan, L., Chen, X., & Bishop, M. J. (2012) · Hepatology · doi:10.1002/hep.25776 · Cited by 103
Notte, A., Ninane, N., Arnould, T., & Michiels, C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.167 · Cited by 100
Albini, A., Morini, M., D’Agostini, F., Ferrari, N., Campelli, F., Arena, G., Noonan, D. M., Pesce, C. M., & Flora, S. D. (2001) · PubMed · Cited by 97
Tan, E. Y., Campo, L., Han, C., Turley, H., Pezzella, F., Gatter, K. C., Harris, A. L., & Fox, S. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1466 · Cited by 97
Subtractive Hybridization of mRNA from early passage and senescent endothelial cells
Grillari, J., Hohenwarter, O., Grabherr, R. M., & Katinger, H. W. D. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00080-2 · Cited by 96
Martinez‐Outschoorn, U., Balliet, R. M., Lin, Z., Whitaker‐Menezes, D., Birbe, R., Bombonati, A., Pavlides, S., Lamb, R., Sneddon, S., Howell, A., et al. (2012) · Cell Cycle · doi:10.4161/cc.22776 · Cited by 90
Moradi, M., Mojtahedzadeh, M., Mandegary, A., Soltan-Sharifi, M. S., Najafi, A., Khajavi, M. R., Hajibabayee, M., & Ghahremani, M. H. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.013 · Cited by 90
Frasci, G., Comella, P., Rinaldo, M., Iodice, G., Bonito, M. D., D’Aiuto, M., Petrillo, A., Lastoria, S., Siani, C., Comella, G., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn748 · Cited by 90
Triple-negative breast cancer: are we making headway at least?
Arnedos, M., Bihan, C., Delaloge, S., & André, F. (2012) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834012444711 · Cited by 90
Degree of Tumor FDG Uptake Correlates with Proliferation Index in Triple Negative Breast Cancer
Tchou, J. C., Sonnad, S. S., Bergey, M. R., Basu, S. K., Tomaszewski, J., Alavi, A. A., & Schnall, M. D. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0294-0 · Cited by 87
Witkiewicz, A. K., Kline, J., Queenan, M., Brody, J. R., Tsirigos, A., Bilal, E., Pavlides, S., Ertel, A., Sotgia, F., & Lisanti, M. P. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15675 · Cited by 86
Senescent Peritoneal Mesothelial Cells Promote Ovarian Cancer Cell Adhesion
Książek, K., Mikuła‐Pietrasik, J., Korybalska, K., Dworacki, G., Jörres, A., & Witowski, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080613 · Cited by 85
The autophagy conundrum in cancer: influence of tumorigenic metabolic reprogramming
Eng, C. H., & Abraham, R. T. (2011) · Oncogene · doi:10.1038/onc.2011.220 · Cited by 85
Overgaard, J. (2000) · Acta Oncologica · doi:10.1080/028418600750013096 · Cited by 85
Singha, P., Pandeswara, S., Venkatachalam, M. A., & Saikumar, P. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.192 · Cited by 83
Reciprocal regulation of ZEB1 and AR in triple negative breast cancer cells
Graham, T. R., Yacoub, R., Taliaferro-Smith, L. D., Osunkoya, A. O., Odero-Marah, V., Liu, T., Kimbro, K. S., Sharma, D., & O'Regan, R. M. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0623-7 · Cited by 83
Keam, B., Im, S., Koh, Y., Han, S., Oh, D., Cho, N., Kim, J. H., Han, W., Kang, K. W., Moon, W. K., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-452 · Cited by 83
New Insights into the Role of the Immune Microenvironment in Breast Carcinoma
de la Cruz‐Merino, L., Barco-Sánchez, A., Henao, F., Fernández, E. N., Benítez, A. V., Molina, J. B., Martínez-Peinado, A., López, A. G., Borrego, M. R., de Villena, M. C. M., et al. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/785317 · Cited by 83
Rakha, E. A., Starczynski, J., Lee, A. H. S., & Ellis, I. O. (2013) · Histopathology · doi:10.1111/his.12357 · Cited by 82
Caspase activation regulates the extracellular export of autophagic vacuoles
Sirois, I., Groleau, J., Pallet, N., Brassard, N., Hamelin, K., Londoño, I., Pshezhetsky, A. V., Bendayan, M., & Hébert, M. (2012) · Autophagy · doi:10.4161/auto.19768 · Cited by 81
Welsh, A. W., Moeder, C. B., Kumar, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.9706 · Cited by 77
Végran, F., Boidot, R., Oudin, C., Riedinger, J., Bonnetain, F., & Lizard‐Nacol, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0725 · Cited by 76
Crown, J. P., Dieras, V. C., Starosławska, E., Yardley, D. A., Davidson, N. G. P., Bachelot, T., Tassell, V. R., Huang, X., Kern, K. A., & Romieu, G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.18_suppl.lba1011 · Cited by 68
Thomas, S., Sharma, N., Golden, E. B., Cho, H., Agarwal, P., Gaffney, K. J., Petasis, N. A., Chen, T. C., Hofman, F. M., Louie, S. G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.030 · Cited by 67
Estrogen-receptor interactions in target tissues.
Jensen, E. V., DeSombre, E. R., Hurst, D. J., et al. (1967) · PubMed · Cited by 67
McCullough, A. E., Dell’Orto, P., Reinholz, M. M., Gelber, R. D., Dueck, A. C., Russo, L., Jenkins, R. B., Andrighetto, S., Chen, B., Jackisch, C., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2827-0 · Cited by 66
Sullivan, R., & Graham, C. H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1090 · Cited by 65
Agarwal, A., Muñoz-Nájar, U., Klueh, U., Shih, S., & Claffey, K. P. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63727-3 · Cited by 64
Bunnell, C. A., Vahdat, L. T., Schwartzberg, L. S., Gralow, J. R., Klimovsky, J., Poulart, V., Peck, R., & Thomas, E. S. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.026 · Cited by 62
αB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer
Ivanov, O., Chen, F., Wiley, E. L., Keswani, A., Diaz, L. K., Memmel, H. C., RADEMAKER, A. W., Gradishar, W. J., Morrow, M., Khan, S. A., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9796-0 · Cited by 61
Giaccone, G., & Pinedo, H. M. (1996) · The Oncologist · doi:10.1634/theoncologist.1-1-82 · Cited by 61
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
Nolen, B. M., Marks, J. R., Ta'san, S., Rand, A., Luong, T. M., Wang, Y., Blackwell, K., & Lokshin, A. E. (2008) · Breast Cancer Research · doi:10.1186/bcr2096 · Cited by 60
Wu, Y., Sarkissyan, M., Elshimali, Y., & Vadgama, J. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078259 · Cited by 59
Cited by
Deepak, K. G. K., Vempati, R., Nagaraju, G. P., Dasari, V. R., S., N., Rao, D. N., & Malla, R. R. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104683 · Cited by 614
Breast Cancer: Current Perspectives on the Disease Status
Fahad Ullah, M. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-20301-6_4 · Cited by 598
Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
Obidiro, O., Battogtokh, G., & Akala, E. O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071796 · Cited by 511
Cazet, A. S., Hui, M. N., Elsworth, B. L., Wu, S. Z., Roden, D., Chan, C.-L., Skhinas, J. N., Collot, R., Yang, J., Harvey, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05220-6 · Cited by 437
Fleury, H., Malaquin, N., Tu, V., Gilbert, S., Martinez, A., Olivier, M.-A., Sauriol, S. A., Communal, L., Leclerc-Desaulniers, K., Carmona, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10460-1 · Cited by 228
Metadata
- Authors
- O’Reilly, E. A., Gubbins, L., Sharma, S., Tully, R., Guang, M. H. Z., Weiner-Gorzel, K., McCaffrey, J., Harrison, M., Furlong, F., Kell, M., & McCann, A.
- Venue
- BBA Clinical
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 3
- Pages
- 257-275
- ISSN
- 2214-6474 (ISSN-L)
- OpenAlex
- W2156871941
- Cited by
- 377
- References
- 226
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.